NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug
NHS chief Simon Stevens has today announced that NHS England has struck a deal with MSD, endorsed by NICE, to make the lung cancer drug pembrolizumab available for routine use on the NHS. New trial results show pembrolizumab extends life for certain adults with lung cancer for more than a year. Pembrolizumab is the first […]